Near summer 2013 range but 2012 was below 1. Falling further could leave it vulnerable to falling to 1, but the biotechs under 10 do not always lend themselves well to classic TA.
Options-related pressures are another distorting influence.
Due diligence on the character of management is often worthwhile in these matters.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.